Pyxis Oncology, Inc.
Pyxis Oncology, Inc. (PYXS) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 62 transactions totaling $28.0M, demonstrating a bullish sentiment with $17.2M in net insider flow. The most recent transaction on Jun 7, 2024 involved a transaction of 6,000 shares valued at $0.
PYXS Insider Activity Summary
Who Is Buying PYXS Stock?
No significant insider buying has been recorded for PYXS in the recent period.
Who Is Selling PYXS Stock?
No significant insider selling has been recorded for PYXS in the recent period.
Is Pyxis Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PYXS is bullish with an Insider Alignment Score of 81/100 and a net flow of $17.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
PYXS Frequently Asked Questions
Understanding PYXS Insider Activity
Insider trading at Pyxis Oncology, Inc. (PYXS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading PYXS stock, having executed 62 transactions in the past 90 days. The most active insider is Mark Chin (Executive), who has made 4 transactions totaling $10.3M.
Related Tools
Track Pyxis Oncology, Inc. Insider Activity
Get notified when executives and directors at PYXS file new Form 4 transactions